References
Avella J, Madsen JE, Binder HJ, Askenase PW. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet 1: 624–626, 1978
Bickel M, Herling AW, Schoelkens B, Scholtholt J. Chemical and biologic characteristics of roxatidine acetate. Scandinavian Journal of Gastroenterology 23 (Suppl. 146): 78–88, 1988
Billingham RE. Free skin grafting in mammals. In Billingham et al. (Eds) Transplantation of tissues and cells, pp. 1–26, The Wister Institute Press, Philadelphia, 1961
Chu D, Wong WL, Mavligit GM. Abrogation of the local xenogeneic graft versus host reaction by preinjection of cimetidine to the immunosuppressed host rats: an experimental model for testing preclinical immunorestorative activity in vivo. Clinical Immunology and Immunopathology 45: 48–57, 1987
Daniel WW. Biostatistics: a foundation for analysis in the health sciences, pp. 203–205, John Wiley & Sons Inc, New York, 1978
Emeson EE, Weintraub FM, Likhite V. Effects of adrenalectomy and glucocorticosteroid therapy on bone marrow T-cells: effect on T-cell traffic and graft-versus-host (GVH) reactivity. Immunopharmacology 4: 311–321, 1982
Gifford RRM, Tilberg AF. Histamine type-2 receptor antagonistimmune modulation II: cimetidine and ranitidine increase interleukin-2 production. Surgery 102: 242–247, 1987
Goldrosen MH, Gannon PJ, Lutz M, Holyoke ED. Isolation of human peripheral blood lymphocytes: modification of a double discontinuous density gradient of ficcol-hypaque. Journal of Immunological Methods 14: 15–17, 1977
Jorizzo JL, Sams WM, Jegasothy BV, Olansky AJ. Cimetidine as an immuno-modulator: chronic mucocutaneous candidiasis as a model. Annals of Internal Medicine 92: 192–195, 1980
Khan MM, Melmon KL. Are autocoids more than theoretic modulators of immunity? Clinical Immunology Reviews 4: 1–30, 1985
Khan MM, Sansoni P, Engleman EG, Melmon KL. Pharmacologic effects of autocoids on subsets of T-cells. Journal of Clinical Investigation 75: 1578–1583, 1985
Lampert IA, Janossy G, Suitters A, Bofill M, Palmer S, et al. Immunological analysis of the skin in graft versus host disease. Clinical and Experimental Immunology 50: 123–131, 1982
Lefford MJ. The measurement of tuberculin hypersensitivity in rats. International Archives of Allergy 47: 570–585, 1974
Mavligit GM, Calvo DB, Patt YZ, Hersh EM. Immune restoration and/or augmentation of local xenogeneic graft versus host reaction by cimetidine in vitro. Journal of Immunology 126: 2272–2274, 1981
Mawhinney H, Killen M, Flemming WA, Roy AD. The hyperimmunoglobulin E syndrome: a neutrophil chemotactic defect reversible by histamine H2-receptor blockade? Clinical Immunology and Immunopathology 17: 483–491, 1980
Rocklin RE. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. Journal of Clinical Investigation 57: 1051–1058, 1976
Rocklin RE, Beer DJ. Histamine and immune modulation. Advances in Internal Medicine 28: 225–251, 1983
Rocklin RE, Habarek-Davidson A. Pharmacologic modulation in vitro of human histamine-induced suppressor cell activity. International Journal of Immunopharmacology 6: 179–186, 1984
Sahasrabudhe DM, McCune CS, O’Donnell RW, Henshaw EC. Inhibition of suppressor T-lymphocytes (Ts) by cimetidine. Journal of Immunology 138: 2760–2763, 1987
Schunack W. What are the differences between the H2-receptor antagonists. Alimentary Pharmacology and Therapeutics 1: 4935–5035, 1987
Simon MR, Salberg DJ, Crane SA. In vivo cimetidine augmentation of phytohemagglutinin-induced human lymphocyte thymidine uptake. Transplantation 31: 400–403, 1981
Snyman JR, Meyer EC, Schoeman HS. Cimetidine as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter. British Journal of Clinical Pharmacology 29: 257–260, 1990
Streilein JW, Billingham RE. Cutaneous hypersensitivity reactions to cellular isoantigens in rats. Journal of Experimental Medicine 126: 445–473, 1967
Talpaz M, Medina JE, Patt YZ, Goepfert H, Guillamondegui OM, et al. The immune restorative effect of cimetidine administration in vivo on the local graft versus host reaction of cancer patients. Clinical Immunology and Immunopathology 24: 155–160, 1982
Thompson RA, Kumararatne DS. Hyper-IgE syndrome and H2-receptor blockade. Lancet 2: 630, 1989
Tonnesen H, Knigge U, Bulow S, Damm P, Fischerman K, et al. Effect of cimetidine on survival after gastric cancer. Lancet 2: 990–992, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snyman, J.R., De Sommers, K. In Vivo Effect of Cimetidine and Roxatidine on the Allogeneic Graft-Versus-Host Reaction. Drug Invest. 3, 130–133 (1991). https://doi.org/10.1007/BF03259553
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259553